Martin E. Dowty

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

Kamran Ghoreschi, Michael I. Jesson, Li Xiong et al. · The Journal of Immunology · 2011 · 644 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis

Debra M. Meyer, Michael I. Jesson, Xiong Li et al. · Journal of Inflammation · 2010 · 459 citations · Full text

Medicine, Immunology, Pharmacology +17

The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis.

Jennifer Hodge, Thomas T. Kawabata, Sriram Krishnaswami et al. · PubMed · 2016 · 372 citations

Medicine, Immunology, Pharmacology +17

The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans

Martin E. Dowty, Jinyan Lin, Tim F. Ryder et al. · Drug Metabolism and Disposition · 2014 · 274 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Plasmid DNA entry into postmitotic nuclei of primary rat myotubes.

Martin E. Dowty, Phillip Williams, G Zhang et al. · Proceedings of the National Academy of Sciences · 1995 · 269 citations

Life Sciences, Cell Biology, Molecular Biology +17